Biotechne revenue
WebSep 30, 2024 · Bio-Techne's revenue growth from 2010 to 2024 is 310.93%. Bio-Techne has 2,250 employees, and the revenue per employee ratio is $491,377. Bio-Techne's …
Biotechne revenue
Did you know?
WebTotal Enterprise Value to Total Revenue (ttm) 11.01. Markets data provided by S&P and by Xignite. Profitability Metrics. Gross Margin (ttm) 68.33%. Operating Margin (ttm) 25.71%. … WebJun 7, 2024 · In terms of fundamentals, Last quarter Bio-Techne reported $1.79 EPS on $243.6 million revenue. Earnings grew 29% last quarter, following 36% and 50% growth the prior two periods. Revenue grew 25% ...
WebAug 5, 2024 · Fourth Quarter FY2024 Snapshot. Fourth quarter organic revenue increased by 39% (47% reported) to $259.0 million. Full year organic growth of 22% (26% reported) … WebApr 14, 2024 · The firm had revenue of $271.58 million during the quarter, compared to the consensus estimate of $289.98 million. As a group, equities analysts forecast that Bio …
WebMay 2, 2024. EPS forecast (this quarter) $0.53. Annual revenue (last year) $1.1B. Annual profit (last year) $271.9M. Net profit margin. 24.60%. WebFeb 2, 2024 · Analysts expected revenue of $206.5 million, for the quarter. Bio-Techne Corporation said its Board of Directors has decided to pay a dividend of $0.32 per share …
Web18 hours ago · The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash ...
WebAug 4, 2024 · Revenue. Net sales for the fourth quarter increased 11% to $288.2 million. Organic growth was 14% compared to the prior year with foreign currency exchange … css table or gridWebApr 14, 2024 · The firm had revenue of $271.58 million during the quarter, compared to the consensus estimate of $289.98 million. As a group, equities analysts forecast that Bio-Techne Co. will post 1.75 ... css table padding 効かないWebFeb 1, 2024 · Second quarter year-over-year organic growth for the segment was 7 percent, with acquisitions contributing 16 percent to revenue growth. Bio-Techne posted Q2 … css table of imagesWebMar 3, 2024 · Bio-Techne anticipates the acquisition to close in the fourth quarter of its fiscal 2024. Founded in 2006, Asuragen is headquartered in Austin, Texas and is a leader in the development, manufacturing and commercialization of genetic carrier screening and oncology testing kits. Asuragen's products leverage proprietary chemistries which can be ... css table overlapping header cells problemWebAug 24, 2024 · The following information was filed by Biotechne Corp (TECH) on Thursday, August 4, 2024 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. ... Revenue - Product Highlight. Organic revenue growth was broad based and driven by overall execution of the Company's long … early 20s meaningWeb2 days ago · The firm has a market cap of $12.24 billion, a PE ratio of 48.32, a price-to-earnings-growth ratio of 2.40 and a beta of 1.25. Bio-Techne Co. has a 52-week low of $68.00 and a 52-week high of $108.19. The company has a quick ratio of 3.15, a current ratio of 4.40 and a debt-to-equity ratio of 0.11. early 20s bedroomWebApr 13, 2024 · Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene … early 20s credit card